China Pharmaceutical Marketing Competitive Strategy.docVIP

 PAGE \* MERGEFORMAT 16 China Pharmaceutical Marketing Competitive Strategy This is a volatile times, new medical reform, medicine and industrial policies, the financial crisis ... ... is also an era full of opportunities, government investment, the market expansion of the external performance of the pharmaceutical industry ... ... more steady, the actual house filled with a number of variables, China pharmaceutical companies for several years has experienced many ups and downs, market competition and corporate transformation everywhere, constantly changing reality, the problem continued exposure. Although you can get through the listing of a large number of development funds, although you can within the enterprise through the IPO to achieve the dream of leadership to become rich, but all in all will be attributable to silence, as a temporary aura can not cover the basic needs of enterprise development - the core competitive edge, We can use the power of capital, to obtain scale advantages, but the eventual development of enterprises and long-term basis for the planning, or business operations from the most basic elements - corporate marketing From EMKT.. This is an era of transformation of China’s pharmaceutical industry, which is a Chinese pharmaceutical enterprises must be the era of choice and return to our main industry, we live to see the root of the journey in the future in order to form our own competitive advantage, the formation of marketing of our own characteristics, can be in the future development of lopsided. Winning Strategy Leadership Action Pharmaceutical industrial and commercial enterprises should be a comprehensive review of its product strategy, marketing strategy, channel strategy, ahead of the overall strategy of the industry on the basis of enterprise development goals, while also changes in the marketing business model, management model, to establish an efficient operational organization and strengthen enforcement. The new situati